Involvement of NK1+CD4-CD8- αβ T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice

Journal of Immunology

Volumn 158, Issue 11, 1997, Pages 5338-5348

  Nakamura, Eijiro ^a   Kubota, Hiroshi ^a   Sato, Masaki ^a   Sugie, Tomoharu ^a   Yoshida, Osamu ^a   Minato, Nagahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD161 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE ANTIGEN; PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; EMBRYONAL CARCINOMA; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; T LYMPHOCYTE SUBPOPULATION; TESTIS TUMOR;

ANIMALS; ANTIGENS; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, SURFACE; CARCINOMA, EMBRYONAL; FLOW CYTOMETRY; IMMUNITY, NATURAL; IMMUNOPHENOTYPING; LECTINS, C-TYPE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; TESTICULAR NEOPLASMS;

EID: 0031157029     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jacob, F. 1977. Mouse teratocarcinoma and embryonic antigens. Immunol. Rev. 33:3.
2. Stevens, L. C. 1958. Studies on transplantable testicular teratomas of strain 129 mice. J. Natl. Cancer Inst. 20:1257.
3. Pierce, G. B. 1967. Teratocarcinoma: model for a developmental concept of cancer. Curr. Top. Dev. Biol. 2:223.
4. 2-microglobulin mRNA expression by mouse embryonal carcinoma cells. Nature 296:260.
5. 2-microglobulin in F9 teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78:5754.
6. Simmler, M. C., and P. R. Avner. 1985. Differential Hm antigen expression on EC cells and early differentiated derivatives. EMBO J. 4:1177.
7. Avner, P. R., W. F. Dove, P. Dubois, J. A. Gaillard, J. L. Guenet, F. Jacob, H. Jacob, and A. Shdlovsky. 1978. The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3. Immunogenetics 7:103.
8. Ostrand-Rosenberg, S., T. M. Rider, and A. Twarowski. 1980. Susceptibility of allogenic mice to teratocarcinoma 402AX. Immunogenetics 10:607.
9. Siegler, E. L., N. Tick, A. K. Teresky, M. Rosenstrauss, and A. J. Levin. 1979. Teratocarcinoma transplantation rejection loci: an H-2-linked tumor rejection locus. Immunogenetics 9:207.
10. Sponaas, A. M., B. Loveland, and E. Simpson. 1988. MHC-unrestricted T-cell cytotoxicity against tumour cells. Immunology 63:233.
11. + double-negative cytotoxic T lymphocytes. Jpn. J. Cancer Res. 84:58.
12. Wagner, H., A. Starzinski Powitz, M. Rollinghoff, P. Golstein, and H. Jakob. 1978. T-cell-mediatcd cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia. J. Exp. Med. 147:251.
13. Stern, P., M. Gidlund, A. Kimura, K. O. Gronvik, and H. Wigzell. 1981. Murine embryonal carcinoma cells: universal targets for mammalian NK cells? Int. J. Cancer 27:679.
14. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016.
15. Yokoyama, W. M., and W. E. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Anna. Rev. Immunol. 11:613.
16. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405.
17. Cartman, G., and R. Gallily. 1985. Lysis of primitive teratocarcinoma cells by non-activated macrophages. Immunol. Lett. 10:207.
18. Bernsteine, E. G., M. L. Hooper, S. Grandchamp, and B. Ephrussi. 1973. Alkaline phosphatase activity in mouse teratoma. Proc. Natl. Acad. Sci. USA 70:3899.
19. 2+-dependent sites. Dev. Biol. 87:340.
20. Hattori, M., H. Okazaki, Y. Ishida, M. Onuma, S. Kano, T. Honjo, and N. Minato. 1990. Expression of murine IL-2 receptor β-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor α-chain transgenic mice. J. Immunol. 144:3809.
21. Malo, D., and E. Skamene. 1994. Genetic control of host resistance to infection. Trends Genet. 10:365.
22. Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 73:469.
23. Staeheli, P., O. Haller, W. Boll, J. Lindenmann, and C. Weissmann. 1986. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147.
24. Scalzo, A. A., P. A. Lyons, N. A. Fitzgerald, C. A. Forbes, W. M. Yokoyama, and G. R. Shellam. 1995. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27:435.
25. Cudkowicz, G., and P. S. Hochman. 1979. Do natural killer cells engage in regulated reactions against self to ensure homeostasis? Immunol. Rev. 44:13.
26. Yu, Y. Y., V. Kumar, and M. Bennett. 1992. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10:189.
27. Golumbek, P. T., A. J. Lazenby, H. I. Levitsky, L. M. Jaffee, H. Karasuyama, M. Baker, and D. M. Pardoll. 1991. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713.
28. Tepper, R. I., P. K. Pattengale, and P. Leder. 1989. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503.
29. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539.
30. Hock, H., M. Dorsch, U. Kunzendorf, Z. Qin, T. Diamantstein, and T. Blankenstein. 1993. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ. Proc. Natl. Acad. Sci. USA 90:2774.
31. Crawford, R. M., D. S. Finbloom, J. Ohara, W. E. Paul, and M. S. Meltzer. 1987. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of la antigens. J. Immunol. 139:135.